[Primary PCI in ST-elevation myocardial infarction: mode of referral and time to PCI]

Pedro Jerónimo Sousa1, Rui Campante Teles, João Brito

  • 1Serviço de Cardiologia, Hospital de Santa Cruz, Carnaxide, Portugal. p965675551@gmail.com

Insights

Compliance with ST-elevation myocardial infarction (STEMI) guidelines for percutaneous coronary intervention (PCI) was low in this tertiary center. Early treatment improved outcomes, with pre-hospital referrals showing the best results.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Acute Myocardial Infarction Management

Context:

  • Current guidelines recommend primary percutaneous coronary intervention (PCI) for ST-elevation myocardial infarction (STEMI) within 90 minutes of first medical contact.
  • Achieving recommended treatment times is crucial for minimizing myocardial damage and improving patient outcomes.
  • This study evaluates adherence to STEMI treatment guidelines in a high-volume, tertiary PCI center.

Purpose:

  • To assess compliance with recommended treatment timelines for STEMI patients undergoing primary PCI.
  • To identify factors influencing treatment delays and variations in guideline adherence.
  • To analyze the relationship between treatment timeliness and clinical outcomes.

Summary:

  • A prospective registry of 223 STEMI patients revealed median total ischemic time of 4.5 hours, with only 4% meeting the <120-minute guideline.
  • Significant delays were observed from symptom onset to first medical contact (median 104 min) and from first ECG to PCI (median 140 min).
  • Pre-hospital emergency system referrals demonstrated shorter ischemic and door-to-balloon times compared to inter-hospital transfers.

Impact:

  • Findings indicate a substantial gap in guideline compliance for primary PCI in STEMI patients.
  • Shorter ischemic times were significantly associated with improved post-PCI myocardial perfusion and ST-segment resolution.
  • Optimizing pre-hospital care and streamlining inter-facility transfers are critical for improving STEMI treatment timeliness and patient outcomes.
Abstract

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...